Leslie dela Cruz

Leslie dela Cruz, PharmD, is an accomplished professional in the field of drug safety and pharmacovigilance, currently serving as Executive Director at Dynavax Technologies since May 2011. With a comprehensive background that includes multiple leadership roles in drug safety operations, Leslie has held positions such as Sr. Director and Director at Dynavax. Previous experience encompasses a tenure at Quark Pharmaceuticals as Sr. Manager and a contractor role at BioSoteria, in addition to various positions at Gilead Sciences focused on safety surveillance and risk management. Leslie began a career in clinical pharmacy at Stanford University Medical Center and gained additional expertise as a Medical Information Specialist at Elan Pharmaceuticals. Academic credentials include a PharmD from the University of California, San Francisco, a pharmacy practice residency at Stanford Hospital and Clinics, and a B.S. in Cell and Molecular Biology from San Francisco State University.